<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Adaptimmune Therapeutics PLC on SEC Form Visualizations</title><link>https://tapaskapadia.github.io/sec-word-clouds/tags/adaptimmune-therapeutics-plc/</link><description>Recent content in Adaptimmune Therapeutics PLC on SEC Form Visualizations</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Tue, 15 Mar 2022 23:19:12 +0000</lastBuildDate><atom:link href="https://tapaskapadia.github.io/sec-word-clouds/tags/adaptimmune-therapeutics-plc/index.xml" rel="self" type="application/rss+xml"/><item><title>Adaptimmune Therapeutics PLC 10-K</title><link>https://tapaskapadia.github.io/sec-word-clouds/posts/adaptimmunetherapeuticsplc_10-k_20220315-231912/</link><pubDate>Tue, 15 Mar 2022 23:19:12 +0000</pubDate><guid>https://tapaskapadia.github.io/sec-word-clouds/posts/adaptimmunetherapeuticsplc_10-k_20220315-231912/</guid><description>Adaptimmune Therapeutics PLC, which is in the Biological Products (No Diagnostic Substances) [2836] industry, SEC 10-K filing on March 14, 2022 had 46457 (cleaned) words - 600 were utilized for the visualizations.
Top Words:
cell - 662 instances may - 533 instances therapies - 492 instances clinical - 455 instances company - 352 instances See the parsed data used in the visualization here.
View the actual filing on the SEC website here</description></item></channel></rss>